Atlas FDA

QUE

1 FDA 510(k) clearances · Product code

FDA profile

Official device name
Spinal Muscular Atrophy Newborn Screening Test System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5980
Medical specialty
Immunology
FDA definition
A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Eonis SCID-SMA Kit (DEN200044)Perkinelmer, Inc.2022-11-09

Track QUE automatically

Every clearance here is in the API, with alerts when new ones post.